前沿生物：2025年度业绩预告

Core Viewpoint - Frontier Biotech announced an expected revenue of approximately 140 million to 145 million yuan for the fiscal year 2025, representing a year-on-year increase of 8.13% to 11.99% [1] - The company anticipates a net loss attributable to shareholders of approximately 255 million to 290 million yuan, which reflects an increase in losses of about 53.6174 million to 88.6174 million yuan compared to the previous year [1] Financial Performance - Expected revenue for 2025 is projected to be between 140 million and 145 million yuan [1] - Year-on-year revenue growth is estimated at 8.13% to 11.99% [1] - Anticipated net loss for 2025 is between 255 million and 290 million yuan [1] - Increase in net loss is projected to be approximately 53.6174 million to 88.6174 million yuan compared to the previous year [1]